Skip to main content

Home/ Medicine & Healthcare/ Group items matching "topical" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
avivajazz jazzaviva

Nonsurgical Treatment Options for Basal Cell Carcinoma | Review Article | Journal of Skin Cancer | 2011 - 0 views

www.hindawi.com/...571734

BCC sBCC studies pubs outcomes efficacy therapy therapies treatment options treatments

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Journal of Skin CancerVolume 2011 (2011), Article ID 571734, 6 pagesdoi:10.1155/2011/571734 © 2011 Mary H. Lien and Vernon K. Sondak.
avivajazz jazzaviva

Efficacy of topical 5% imiquimod cream for the tre... [Arch Dermatol. 2002] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...12224977

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies cream

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Topical 5% imiquimod cream is well tolerated and most effective in treating nodular BCC when applied once daily for 7 days per week for either 12 or 6 weeks.
avivajazz jazzaviva

Aldara ~ Prior Authorization Guideline - 0 views

www.prescriptionsolutions.com/...Guideline_3016.pdf

insurance medical preapproval priorauthorization prior-authorization authorization

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Superficial Basal Cell Carcinoma Aldara™ cream is indicated for the topical treatment of biopsy-confirmed, primary superficial basal cell carcinoma (sBCC) in immunocompetent adults, with a maximum tumor diameter of 2.0 cm, located on the trunk (excluding anogenital skin), neck, extremities (excluding hands and feet), only when surgical methods are medically less appropriate and patient follow-up can be reasonably assured.  The histological diagnosis of superficial basal cell carcinoma should be established for other types of basal cell carcinomas, including nodular, morpheaform (fibrosing or sclerosing) types.
avivajazz jazzaviva

Mohs Surgery Animation Handout - Doctor recommended review - 0 views

fromyourdoctor.com/topic.do

mohs BCC basalcellcarcinoma video animation videos animations graphics

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Mohs surgery technique is is typically reserved for skin cancers that have a high risk of reappearing or for skin cancers that have recurred. Mohs surgery is also a preferred option for removing skin cancer from areas such as the face
avivajazz jazzaviva

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream | Alessi SS, et al | CLINICS 2009;64(10):961-6 - 0 views

www.ncbi.nlm.nih.gov/...cln_64p961.pdf

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies pdf

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
    • avivajazz jazzaviva
      avivajazz jazzaviva on 24 Jul 11
       
      For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
  • avivajazz jazzaviva on 24 Jul 11
     
    For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
avivajazz jazzaviva

Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. [J Eur Acad Dermatol Venereol. 2009] - PubMed - 0 views

www.ncbi.nlm.nih.gov/...19646136

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies 1-year 2-year followup

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Clinical clearance rate at 1 and 2 years were 89% and 85%, respectively.
avivajazz jazzaviva

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream - 0 views

www.ncbi.nlm.nih.gov/...PMC2763070

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    For patients without comorbidities, our study revealed good cure rates for superficial BCC and superficial/nodular BCC (88% and 85%, respectively). Nodular and aggressive BCC and Bowen's disease exhibited lower cure rates (50%, 50%, and 57%, respectively). I
avivajazz jazzaviva

Treatment of cutaneous tumors with topical 5% imiq... [Clinics (Sao Paulo). 2009] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...19841702

BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    For patients without comorbidities, the overall cure rate was 73%. For these patients, the cure rates were 85.7% for superficial and nodular BCC, 88% for superficial BCC, 57% for Bowen's disease, 50% for nodular BCC, and 50% for aggressive BCC.
1 - 20 of 35 Next ›
Showing 20▼ items per page